The US Food and Drug Administration (FDA) has updated 17 draft product-specific guidances (PSGs) to assist sponsors in submitting abbreviated new drug applications (ANDAs) for injectable peptide ...
The Centers for Medicare & Medicaid Services July 30 released the fiscal year 2027 final rule for inpatient rehabilitation facilities. The rule will increase payments by 2.3% overall, which includes a ...
KFF who wins under CMS 340B proposal reveals safety-net hospitals face revenue cuts while rural and small urban hospitals gain in 2027 Medicare rule.
The Centers for Medicare and Medicaid Services’ recent proposal to overhaul Medicare’s reimbursement rates for 340B drugs will be a drag on many large hospitals and those treating a disproportionate ...
Heyyy, it’s a brand new week, and this is the Health Brief newsletter. The House has left for August recess, but the Senate ...
Griffin claims that major drug manufacturers are blocking healthcare providers from participating in 340B, a federal law ...
The CY 2027 OPPS proposed rule features a modest rate update, aggressive site-neutral expansions, and significant cuts to ...
B is a federal program that requires pharma companies to provide discounted drugs for hospitals and clinics that serve ...
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2027 Hospital Outpatient Prospective Payment System (OPPS) ...
The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts ...
The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, ...
The 340B program was created to help patients access medications at lower costs by allowing hospitals and clinics to purchase drugs at steep discounts. On paper, it sounds like exactly what cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results